HOXC8-activated TRIM22/NF-κB pathway promotes stemness in colorectal cancer.
1/5 보강
Colorectal cancer (CRC) remains a significant global health challenge and is characterized by high incidence and mortality rates.
APA
Tan S, Chen Y, et al. (2026). HOXC8-activated TRIM22/NF-κB pathway promotes stemness in colorectal cancer.. Cancer letters, 638, 218156. https://doi.org/10.1016/j.canlet.2025.218156
MLA
Tan S, et al.. "HOXC8-activated TRIM22/NF-κB pathway promotes stemness in colorectal cancer.." Cancer letters, vol. 638, 2026, pp. 218156.
PMID
41265630
Abstract
Colorectal cancer (CRC) remains a significant global health challenge and is characterized by high incidence and mortality rates. Although the homeobox gene family has been implicated in oncogenic processes, the precise functional role of HOXC8 in regulating CRC proliferation and stemness remains poorly defined. Cancer cells with stem-related properties, a distinct cellular subpopulation endowed with self-renewal and differentiation capacities, play pivotal roles in tumor initiation, metastasis, and therapeutic resistance. In this study, we demonstrate that HOXC8 overexpression promotes CRC cell proliferation, enhances stemness properties, and confers chemoresistance. Mechanistically, HOXC8 transcriptionally activates TRIM22, leading to the ubiquitination and degradation of IκBα, which subsequently potentiates NF-κB signaling to drive stemness maintenance in CRC cells. These findings delineate a previously unrecognized HOXC8/TRIM22/NF-κB signaling axis that critically regulates tumor progression, offering a promising molecular target for therapeutic intervention in CRC.
MeSH Terms
Humans; Colorectal Neoplasms; Homeodomain Proteins; Signal Transduction; NF-kappa B; Neoplastic Stem Cells; Cell Proliferation; Tripartite Motif Proteins; Animals; Gene Expression Regulation, Neoplastic; Cell Line, Tumor; Ubiquitination; Drug Resistance, Neoplasm; Mice
같은 제1저자의 인용 많은 논문 (5)
- Visual Disturbance and Elevated Glutamic Acid Decarboxylase Antibody Levels as Manifestations of Central Nervous System Lymphoma.
- Dietary advice alone or with oral nutritional supplements after hospital discharge in colorectal cancer surgery patients: Five year follow-up of a randomized controlled trial.
- Ceritinib-ibuprofen synergistic hepatotoxicity: Insights from real-world data and liver organoid models.
- Primary sinonasal DLBCL: High prevalence of MCD subtype and CNS risk.
- Cardiovascular risk in cancer patients treated with immune checkpoint inhibitors: challenges and future directions.